John B. Henneman, III
2017 - NewLink Genetics
In 2017, John B. Henneman, III earned a total compensation of $1.5M as Chief Financial Officer & Secretary at NewLink Genetics, a 57% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $137,200 |
|---|---|
| Option Awards | $964,516 |
| Salary | $407,308 |
| Other | $33,863 |
| Total | $1,542,887 |
Henneman received $964.5K in option awards, accounting for 63% of the total pay in 2017.
Henneman also received $137.2K in non-equity incentive plan, $407.3K in salary and $33.9K in other compensation.
Rankings
In 2017, John B. Henneman, III's compensation ranked 6,820th out of 14,666 executives tracked by ExecPay. In other words, Henneman earned more than 53.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,820 out of 14,666 | 54th |
Division Manufacturing | 2,528 out of 5,772 | 56th |
Major group Chemicals And Allied Products | 818 out of 2,075 | 61st |
Industry group Drugs | 632 out of 1,731 | 64th |
Industry Pharmaceutical Preparations | 498 out of 1,333 | 63rd |
Source: SEC filing on April 9, 2018.
Henneman's colleagues
We found four more compensation records of executives who worked with John B. Henneman, III at NewLink Genetics in 2017.